K51.0 - Ulcerative Colitis of the Colon (Pancolitis)
K51.0 is the ICD-10 code for ulcerative colitis of the colon (pancolitis), a chronic inflammatory bowel disease causing mucosal ulceration throughout the entire large intestine.
Things worth knowing about "K51.0"
K51.0 is the ICD-10 code for ulcerative colitis of the colon (pancolitis), a chronic inflammatory bowel disease causing mucosal ulceration throughout the entire large intestine.
What Does the ICD-10 Code K51.0 Mean?
The ICD-10 code K51.0 refers to ulcerative colitis of the colon, also known as pancolitis. This is a form of ulcerative colitis in which the inflammation affects the entire colon (large intestine). Ulcerative colitis is a chronic inflammatory bowel disease (IBD) characterized by recurring inflammation and ulcers (sores) of the intestinal mucosa.
Causes
The exact cause of ulcerative colitis has not yet been fully established. A combination of several factors is believed to be involved:
- Genetic predisposition: Certain gene variants increase the risk of developing ulcerative colitis.
- Immune system dysregulation: The immune system mistakenly attacks the lining of the bowel.
- Alterations in the gut microbiome: An imbalance of intestinal bacteria may contribute to the disease.
- Environmental factors: Diet, stress, and hygiene conditions may play a role.
Symptoms
Since K51.0 involves the entire colon, symptoms are often more pronounced than in localized forms of ulcerative colitis:
- Frequent, often bloody diarrhea
- Crampy abdominal pain, especially before bowel movements
- Urgent need to defecate (tenesmus)
- Weight loss and loss of appetite
- Fatigue and general weakness
- Fever during acute flares
- Extraintestinal manifestations such as joint pain, skin changes, or eye inflammation
Diagnosis
The diagnosis of K51.0 is established through a combination of clinical, laboratory, and endoscopic investigations:
- Colonoscopy: The gold standard for assessing mucosal changes and obtaining tissue samples (biopsy)
- Histological examination: Microscopic analysis of tissue samples to confirm the diagnosis
- Blood tests and inflammatory markers: Elevated CRP levels, leukocytosis, anemia
- Stool analysis: To exclude infectious causes; fecal calprotectin as a marker of intestinal inflammation
- Imaging (MRI, ultrasound): To assess complications
Treatment
The treatment of ulcerative colitis K51.0 depends on the severity of the flare and the extent of the disease. The goals are to induce and maintain remission:
Medical Therapy
- Aminosalicylates (e.g., mesalazine): First-line treatment for mild to moderate disease
- Corticosteroids: Used for short-term management of acute flares
- Immunosuppressants (e.g., azathioprine, 6-mercaptopurine): For frequent flares or steroid dependence
- Biologics (e.g., infliximab, vedolizumab, ustekinumab): For moderate to severe disease or failure of standard therapy
- JAK inhibitors (e.g., tofacitinib): A newer oral treatment option for moderate to severe ulcerative colitis
Surgical Therapy
In cases of severe, therapy-refractory disease, complications such as toxic megacolon, or increased cancer risk, a proctocolectomy (surgical removal of the colon and rectum) may become necessary.
Diet and Lifestyle
A balanced diet, stress reduction, and regular medical check-ups are important components of self-management. During an acute flare, a low-fiber, easily digestible diet may be beneficial.
Complications
Extensive pancolitis (K51.0) carries a higher risk of complications than localized forms of the disease:
- Toxic megacolon (life-threatening dilation of the colon)
- Increased risk of colorectal cancer with long-standing disease
- Primary sclerosing cholangitis (a disease of the bile ducts)
- Osteoporosis due to long-term steroid therapy
References
- European Crohn's and Colitis Organisation (ECCO): ECCO Guidelines on Ulcerative Colitis, 2022. Available at: https://www.ecco-ibd.eu
- World Health Organization (WHO): International Classification of Diseases, 10th Revision (ICD-10). Available at: https://www.who.int/standards/classifications/classification-of-diseases
- Ordas I, Eckmann L, Talamini M, Baumgart DC, Sandborn WJ. Ulcerative colitis. Lancet. 2012;380(9853):1606-1619. doi:10.1016/S0140-6736(12)60150-0
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Verwandte Produkte
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.